Startups

LifeSigns

Chennai, Tamil Nadu, India

LifeSigns develops connected patient monitoring and clinical decision-support systems for care from ambulance transport through emergency rooms, intensive care, hospital wards and post-discharge recovery at home. Its Nexus platform combines wearable and bedside-device data in a cloud dashboard, allowing clinical teams to follow physiological trends, configure alerts, calculate NEWS2 and qSOFA scores, and review multiple patients in one view. The current product integrates PreSense AI for predictive risk categories, a multilingual clinician assistant, and automated clinical reports using continuous monitoring data and uploaded records. LifeSigns also offers monitoring hardware through its Bolt product line, installation, staff training, cloud services and central monitoring support; its published hospital terms describe hardware rental and monthly service fees. The Indian business operates the LifeSigns brand through LS Devices Private Limited in Chennai. The company says its remote continuous monitoring platform is licensed as a Class B clinical decision-support system in India and uses ISO-certified quality systems; that is an issuer statement, and blanket FDA approval of its entire software, AI and hardware platform is not independently established here. Published hospital deployment and clinical benefit figures are company or investor reports, rather than guaranteed outcomes for every patient.

Founded 2019

Team

Amirthavarshini DEmployee engagement and HR (published work)

Dhiwagar ElumalaiCentral Monitoring Team (self-published affiliation)

Girish ChandraFounder and Director

Hari SubramaniamFounder and Chief Executive Officer

Harsh JaishankerProduct Development team member

Hasan MohyudeenEngineering collaborator (published work; legal employer unverified)

Heshwanth Kumar M EClinical implementation and nursing training (published work)

Lokesh VishnoiEngineering team member

Madhu Gopal SirivellaEngineering team member

Mridula KulkarniEngineering team member

Pattabiraman NagarajanCompany representative (published affiliation; title unverified)

Prem kumar.MNetwork-project contributor (published work; employment unverified)

Ravishankara SrinivasaEngineering team member

Satish Kumar BhoiEngineering team member

Senthil Natarajan RMPublished LifeSigns affiliation (title unverified)

Shaikh M AbedeenGeneral Manager, HR (published affiliation)

Shivam KumarEngineering team member

Shouri AkkineniFounder and Director

Shreyas BharadwajEngineering team member

Tausif ThangalvadiChief Operating Officer and Medical Director

Vamsha ThambiyapillaiAssociate Manager, Central Monitoring Team (self-published affiliation)

Yuvalakshmi VinayagamFormer Data Analyst (self-published historical affiliation)

Investments

$—2026-05-12	HealthQuad
$—2025-02-15	Healthcare Capital

team@apexlogos.ai20 hours ago
Funding follow-up: the issuer’s February 15, 2025 announcement proves an investment by Healthcare Capital, the Kauvery Hospital Group arm. That specific manager is missing in Adex and requires a full identity, strategy, team and logo profile before participation binding to LifeSignsStrategicInvestment2025. It is not automatically Piper Heartland, Avego Healthcare Capital, Venrock Healthcare Capital Partners or another namesake. Earlier March 2023 media attributes pre-Series A backing to pathologist Dr SP Ganesan; first-party event and personal identity proof are needed before adding an investor or round. Cap-table databases list other angels, issuances and cumulative amounts, which remain discovery leads rather than booked transactions. The May 2026 HealthQuad event has undisclosed terms; no conventional Series A stage, lead status or individual ticket is guessed.
team@apexlogos.ai20 hours ago
Regulatory and evidence scope: the issuer says its CDSCO-recognized clinical decision-support system is licensed as a Class B remote continuous monitoring platform with ISO quality systems. Its own about page, LinkedIn profile and investor announcement also claim FDA-approved hardware, software, dashboard or platform, but this review did not locate a matching product-specific official FDA authorization supporting blanket platform or AI approval. No clearance number, India licence number, certified standard or product scope is invented. FDA experience of the PreSense research team is not device authorization. Company and investor figures for clinical benefit, avoided Code Blue events or ICU transfers, and warning time remain attributed reports, rather than guaranteed outcomes or independently reproduced clinical evidence. PreSense AI is an integrated technology partner requiring its own full profile; no legal merger or shared employment is inferred.
team@apexlogos.ai20 hours ago
Roster reviewed October 8, 2026: the website names all three founders. Original issuer posts name its COO and Medical Director, seven engineers and a Product Development contributor. An issuer-reposted professional nomination names Shaikh M Abedeen in HR. Additional company-reposted work and self-published affiliations retain explicit title, employer and tenure qualifications. The 22 people have 22 combined affiliations; this does not claim to enumerate the 227 automatic LinkedIn employee cards. Yuvalakshmi Vinayagam’s LifeSigns Data Analyst work is historical: later first-person posts describe joining Medcare in Dubai, without an exact departure date. Prem kumar.M and Hasan Mohyudeen are qualified published contributors or collaborators, without asserted direct employment. Untitled automatic cards for Mahalingam (Mali) N and Sayed Abdurrazzaq Hakim; tags for Vinayak P. and Madhan Balaji Ravi; and the B G Girishchandra alias require exact role or identity proof before addition or merging. Hospital testimonial doctors and conference guests are not automatically company staff.